Biomarker-based staging of Alzheimer disease: rationale and clinical applications
Douglas Mental Health University Institute · Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean · +23 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
157
total citations
- FWCI
- 52.62
- Percentile
- 100%
- References
- 205
Citations per year
Authors
23- JTJoseph TherriaultCorresponding
Douglas Mental Health University Institute, Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean, Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal, McGill University
- SESuzanne E. Schindler
Washington University in St. Louis
- GSGemma Salvadó
Lund University
- TATharick A. Pascoal
University of Pittsburgh
- ALAndréa Lessa Benedet
University of Gothenburg
Topics & keywords
Topics
Keywords
- Biomarker
- Disease
- Medicine
- Oncology
- Internal medicine
- Biology
- Genetics
UN Sustainable Development Goals
- Peace, Justice and strong institutions
No related works found for this paper.
Funding
- AAAlzheimer's AssociationAwards: NIRP-12-259245, 34874, 33397, NIRG-12-92090
- FBFondation Brain CanadaAwards: 2020-VICO-279314, 34874, 33397
- WBWeston Brain Institute
- CCConsortium canadien en neurodégénérescence associée au vieillissement
- CICanadian Institutes of Health ResearchAwards: MOP-11-51-31, 152985, RFN 152985, 159815, 162303, 92090
- FDFonds de Recherche du Québec - SantéAward: 2020-VICO-279314